5 Ways DIY Market Intelligence Adds Value to Your Daily Decision Making

Doing something without the aid of experts or professionals, DIY or do-it-yourself, is a current trend across many different industries. I did a quick Google search on the topic, narrowing it down to our space of market intelligence and business research. The results speak for themselves.

Why has DIY become such a hot topic within the research community? Talking with customers and industry experts a few reasons seem to resonate…

  • Potential cost savings
  • Speed and flexibility
  • Security of proprietary data
  • Complete knowledge of research needs

As a company providing market intelligence tools to support your daily business decisions we think DIY not only makes sense but adds value.

5 Reasons DIY is a Value Add in the Pharmaceutical Industry

 

  1. DIY offers immediate clarity on internal business issues and questions; providing actionable insights. Breaking from the traditional: gaining actionable customer insights shares a real world case study.
  2. Need to know what’s happening in your market – today? Run a quick competitive analysis with your target audience.
  3. Nothing is lost in translation, you know your company and needs better than anyone else. You’re the expert in 3 benefits of do-it-yourself research.
  4. Have a strategy meeting this coming Friday? Need to be prepared with business intelligence to share during the meeting? Run a DIY study; get immediate market feedback from your target audience.
  5. Run an agile product launch. Query physicians within hours of initial product detailing, immediately inform the launch process. 

DIY is synonymous with agile. DIY market intelligence allows you to quickly understand and react to your market and customers. At InCrowd we understand the importance of being agile and the need to easily access market information to support daily business decisions.

With this in mind, InCrowd will soon offer a completely DIY market intelligence tool. We’re putting you in the role of expert. You know your company and business better than anyone else, this is your opportunity to quickly and directly ask the questions you need answered.

Watch for an InCrowd product announcement in the coming days, and follow us on Twitter @InCrowdNow to stay up to date with the latest InCrowd news.

INBOUND and Pharma: Don’t be pushy, be human

bigstock-abstract-puzzle-people-backgro-13869878Is the pharmaceutical industry ready for inbound marketing? 

That was my burning question prior to the start of INBOUND 2013.

Initially I thought yes, today I think yes – beyond a doubt. 

I came back with a few takeaways to share with the pharma industry.

INBOUND Takeaway: Be Human 

Historically marketing has been pushy. As a company marketer your job was to push out product information and offerings regardless of timing or customer need.

In today’s connection economy these efforts are typically less than successful. 23 Reasons Inbound Marketing Trumps Outbound Marketing tells us:

  • 44% of direct mail is never opened
  • Communication is ‘one-way’ with old marketing efforts
  • 91% of people have unsubscribed from company emails they previously opted into
  • Old marketing efforts provide little to no added value

So how can we be successful? How can we connect with our customers? Dharmesh Shah, HubSpot co-founder, summed it very eloquently when he said, “inbound marketing solves for the humans.”

Your customers are not a database of contact information; they are individual human beings. I think this is even truer in the healthcare space. These are patients, caregivers, family members and they want to be treated with respect. Inbound marketing provides the pharmaceutical industry with a wonderful opportunity to connect with individuals vs. a patient population.

My week spent at INBOUND 2013 confirmed what I thought from the start, inbound marketing can be a great asset for the pharmaceutical industry and the time to begin these efforts is now.

This post originally appeared on CROWDTalk. 

INBOUND and Pharma: Entering the connection economy

INBOUND 2013 had me wondering… Is the pharmaceutical industry ready for inbound marketing?

I said absolutely and the inbound perspective is needed now more than ever. I came back with a few takeaways to share with the pharma industry.

INBOUND Takeaway: It’s All About the Connection

Seth Godin was the opening keynote at INBOUND 2013. Personally I can’t help but be motivated and inspired when I hear Seth speak and this time was no different. His main message was that like it or not – we’re all inbound. Gone are the days of it’s all about me or my company, people don’t want to do business with the self-absorbed. It’s all about the connection. Successful companies will be those that make an effort to understand and truly connect with their customers.

We are leaving the industrial economy and entering the connection economy. Seth told us, “building connections is the asset of the future.” I can’t think of a better takeaway for the pharmaceutical industry – connect with your customers.

I see another perfect opportunity for pharma to go inbound. What do you think? How can pharma connect with the health consumer? What pharma companies are already making the connection?